ethyl 3-methyl-5-oxo-2-propyl-2,5-dihydroisoxazole-4-carboxylate | 868551-38-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: ethyl 3-methyl-5-oxo-2-propyl-2,5-dihydroisoxazole-4-carboxylate
• 英文别名: ethyl 3-methyl-5-oxo-2-propyl-1,2-oxazole-4-carboxylate
• CAS: 868551-38-6
• 化学式: C₁₀H₁₅NO₄
• 分子量: 213.233
• InChiKey: JTNYEDJAMCUQOD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  ethyl 3-methyl-5-oxo-2-propyl-2,5-dihydroisoxazole-4-carboxylate 在 盐酸 、 溶剂黄146 作用下， 以 水 为溶剂， 反应 8.0h， 以100%的产率得到N-propylhydroxylamine hydrochloride
  参考文献：
  名称：

  [EN] PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS HIV-INTEGRASE INHIBITORS
  [FR] INHIBITEURS DE L'ENZYME INTEGRASE DU VIH

  摘要：

  公开号：

  WO2005103003A3
• 作为产物：
  描述：

  ethyl 3-methyl-5-oxo-2,5-dihydroisoxazole-4-carboxylate sodium salt 、 1-碘代丙烷 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 以13%的产率得到ethyl 3-methyl-5-oxo-2-propyl-2,5-dihydroisoxazole-4-carboxylate
  参考文献：
  名称：

  Azaindole Hydroxamic Acids are Potent HIV-1 Integrase Inhibitors

  摘要：

  HIV-1 integrase (IN) is one of three enzymes encoded by the HIV genome and is essential for viral replication. Recently, HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Herein, we report the discovery of azaindole carboxylic acids and azaindole hydroxamic acids as potent inhibitors of the HIV-1 IN enzyme and their structure-activity relationships. Several 4-fluorobenzyl substituted azaindole hydroxamic acids showed potent antiviral activities in cell-based assays and offered a structurally simple scaffold for the development of novel HIV-1 IN inhibitors.

  DOI：

  10.1021/jm900862n

文献信息

• Inhibitors of the HIV integrase enzyme
  申请人：Dress Ruprecht Klaus

  公开号：US20050277662A1

  公开（公告）日：2005-12-15

  The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.

  本发明涉及公式（I）的化合物，以及其药学上可接受的盐和溶剂化物，它们的合成以及它们作为人类免疫缺陷病毒（“HIV”）整合酶酶的调节剂或抑制剂的用途。
• PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS HIV-INTEGRASE INHIBITORS
  申请人：Pfizer, Inc.

  公开号：EP1756103A2

  公开（公告）日：2007-02-28
• US7468375B2
  申请人：——

  公开号：US7468375B2

  公开（公告）日：2008-12-23
• [EN] INHIBITORS OF THE HIV INTEGRASE ENZYME<br/>[FR] INHIBITEURS DE L'ENZYME INTEGRASE DU VIH
  申请人：PFIZER

  公开号：WO2005103003A2

  公开（公告）日：2005-11-03

  The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.